Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Min Gi Cha"'
Autor:
Ki-Kwang Oh, Haripriya Gupta, Byeong Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung Min Won, Jin Ju Jeong, Su Been Lee, Min Gi Cha, Goo Hyun Kwon, Min Kyo Jeong, Ji Ye Hyun, Jung A Eom, Hee Jin Park, Sang Jun Yoon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract The metabolites of gut microbiota show favorable therapeutic effects on nonalcoholic fatty liver disease (NAFLD), but the active metabolites and mechanisms against NAFLD have not been documented. The aim of the study was to investigate the a
Externí odkaz:
https://doaj.org/article/77ddfc486aac480a9b650c4807f99fee
Autor:
Jin-Ju Jeong, Hee Jin Park, Min Gi Cha, Eunju Park, Sung-Min Won, Raja Ganesan, Haripriya Gupta, Yoseph Asmelash Gebru, Satya Priya Sharma, Su Been Lee, Goo Hyun Kwon, Min Kyo Jeong, Byeong Hyun Min, Ji Ye Hyun, Jung A Eom, Sang Jun Yoon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk
Publikováno v:
Microorganisms, Vol 10, Iss 2, p 288 (2022)
Over the past decade, scientific evidence for the properties, functions, and beneficial effects of probiotics for humans has continued to accumulate. Interest in the use of probiotics for humans has increased tremendously. Among various microorganism
Externí odkaz:
https://doaj.org/article/3ef82ae13e9c4ef9be53555bf45e01bf
Autor:
Ki-Kwang Oh, Ye-Rin Choi, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Dong-Joon Kim, Ki-Tae Suk
Publikováno v:
Current Issues in Molecular Biology, Vol 44, Iss 7, Pp 3253-3266 (2022)
Alcoholic liver disease (ALD) is linked to a broad spectrum of diseases, including diabetes, hypertension, atherosclerosis, and even liver carcinoma. The ALD spectrum includes alcoholic fatty liver disease (AFLD), alcoholic hepatitis, and cirrhosis.
Externí odkaz:
https://doaj.org/article/17099489a8fd40bf990605c9ff0b6016
Autor:
Ki-Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology. 51:217-232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b5a277b0c1cd6ff73e68d6f15385b02
https://doi.org/10.1080/21691401.2023.2203734
https://doi.org/10.1080/21691401.2023.2203734
Autor:
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong-Joon Kim, Ki-Tae Suk
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 550 (2022)
Non-alcoholic fatty liver disease (NAFLD) is considered to be a significant health threat globally, and has attracted growing concern in the research field of liver diseases. NAFLD comprises multifarious fatty degenerative disorders in the liver, inc
Externí odkaz:
https://doaj.org/article/754698285e0f46488beaaf303411af5a
Autor:
Ki-Kwang Oh, Ickwon Choi, Gupta, Haripriya, Raja, Ganesan, Sharma, Satya Priya, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Publikováno v:
Artificial Cells, Nanomedicine & Biotechnology; 2023, Vol. 51 Issue 1, p1-12, 12p
Autor:
Ki-Kwang Oh, Ickwon Choi, Haripriya Gupta, Ganesan Raja, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Publikováno v:
Artificial cells, nanomedicine, and biotechnology. 51(1)
We intended to identify favourable metabolite(s) and pharmacological mechanism(s) of gut microbiota (GM) for liver regeneration (LR) through network pharmacology. We utilized the gutMGene database to obtain metabolites of GM, and targets associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2fcb423d75872b7db592afde46c285b
https://pubmed.ncbi.nlm.nih.gov/36562095
https://pubmed.ncbi.nlm.nih.gov/36562095
Autor:
Su-Been Lee, Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Kwang Oh, Ki-Tae Suk
Non-alcoholic fatty liver disease (NAFLD) is an initial etiology to be developed steatosis, liver fibrosis, cirrhosis, and even hepatocellular carcinoma. However, the noticeable therapeutics were not elucidated completely to dampen the progressive ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad63fcb452566b7a27e998fe16fe83f6
https://doi.org/10.21203/rs.3.rs-2107064/v1
https://doi.org/10.21203/rs.3.rs-2107064/v1
Autor:
Ki-Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Byeong-Hyun Min, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Background Nonalcoholic fatty liver disease (NAFLD) has been issued in a wide range of complicated progressive interruption such as steatosis, fibrosis, cirrhosis, and even hepatocellular carcinoma. However, a key therapy to unravel the progressive d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e29b3b35fa551f95ffe4d115fed0959b
https://doi.org/10.21203/rs.3.rs-1996432/v1
https://doi.org/10.21203/rs.3.rs-1996432/v1
Autor:
Ki-Kwang Oh, Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Dong Joon Kim, Ki-Tae Suk
Publikováno v:
Cells. 11(18)
The metabolites produced by the gut microbiota have been reported as crucial agents against obesity; however, their key targets have not been revealed completely in complex microbiome systems. Hence, the aim of this study was to decipher promising pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9610c89c324619ef0317ef251e1d2ac
https://pubmed.ncbi.nlm.nih.gov/36139478
https://pubmed.ncbi.nlm.nih.gov/36139478